Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04788459
Recruitment Status : Active, not recruiting
First Posted : March 9, 2021
Last Update Posted : December 21, 2021
Rottapharm Biotech
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : September 2022